CVC and GBL secure 91.9% of Recordati in takeover offer
Italian pharmaceutical company Recordati, listed in Milan, has cleared the 90% threshold needed to delist after a €53 per share offer.
- Target
- Recordati
- Buyer
- CVC Capital Partners and GBL consortium
- Sponsor
- CVC Capital Partners, GBL
- Value
- €11 billion
- Status
- Completed
The holding passed the 90% delisting threshold after more shares were tendered on Monday, 9 November, and clears the way for Recordati to leave the Milan stock exchange. The consortium offered €53 per share, with the tender period closing at 16:30 GMT.
Recordati is an Italian pharmaceutical company, which the source describes as an €11bn business. The 91.9% figure was calculated by Reuters using Borsa Italiana data and excludes any shares CVC or GBL bought on the market on the final day of the offer.
Correction
This article previously gave the announcement date as September 14. CVC and GBL announced the tender offer for Recordati on May 22, 2026, and the date has been corrected. The article reports the result of that offer.
Background
- Business
- Italian pharmaceutical company listed on the Milan stock exchange, described as a €11bn business
- Deal type
- Platform
Sources
- Private Equity WireNov 10, 2026
- ad-hoc-news.deSep 14, 2026
- GBLMay 22, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.